AsianScientist (Jan. 09, 2026) – When Factor Biosciences launched in 2017, the present state of genomics pressured labs to decide on both efficiency or affordability. At this time, the corporate has confirmed that researchers can have the very best of each. Factor’s merchandise ship high-accuracy sequencing and built-in multi-omics at considerably decrease working prices, empowering labs of all sizes to pursue formidable analysis.
Throughout the Asia-Pacific area, 50 Factor platforms are actually accelerating discoveries in analysis establishments, medical labs and biotech corporations. Molly He, co-founder of Factor Biosciences, discusses how the corporate constructed an ecosystem for organic discovery and what’s subsequent for genomics innovation.
1. Factor Biosciences was based in 2017. What hole did you and your co-founders determine, and the way did you envision addressing it?
My co-founders and I noticed a transparent hole between what scientists wanted and what legacy applied sciences may ship. ‘Democratize’ will get used rather a lot on this house, but it surely genuinely captures our mission: bringing high-quality sequencing and multi-omics instruments to labs of all sizes and useful resource ranges. Finally, we need to form the way forward for precision drugs into one thing each reasonably priced and accessible.
At our core, we’re a biology firm. We begin by asking, “What does the scientist want to grasp biology higher?” Then we construct the know-how to reply these questions.
2. Why is accessibility so important to Factor’s mission?
Science is iterative by nature. Every discovery permits the subsequent. However when breakthrough instruments are accessible solely to essentially the most well-resourced labs, progress slows for everybody.
Better entry to high-quality sequencing and multi-omics accelerates analysis, fuels earlier illness detection and helps sooner drug growth. It ensures that transformative science isn’t restricted by geography or sources.
3. Factor’s development has been exceptional. What do you credit score for the corporate’s fast success?
I discovered early on that momentum is constructed on belief. Everybody within the group must belief one another. Typically meaning making necessary selections with out full data. That shared confidence permits us to behave rapidly in fixing actual scientific challenges. The momentum we’ve at this time is a direct reflection of a group unified by function and belief.
4. Your AVITI system was Factor’s first DNA sequencing platform. What problem was it designed to resolve?
AVITI was designed to eradicate the trade-off between efficiency and price that lengthy restricted genomics. It delivers distinctive accuracy, versatile throughput, and considerably decrease working prices. This mixture empowers labs of all sizes to scale sequencing with out compromising analysis targets.
The system was additionally engineered for simplicity. Labs can undertake it rapidly with out altering present processes. This ease of integration has been a key driver of worldwide uptake.
5. How do your Trinity™ sequencing kits complement AVITI, and what affect have they got collectively?
Trinity sequencing kits streamline one of the crucial time-consuming steps in focused sequencing. They transfer key seize, wash and sequencing steps immediately onto the AVITI system, which eliminates specialised gear. In flip, as much as 5 hours of handbook work is decreased, enabling same-day sequencing with quick hybridization.
Collectively, Trinity and AVITI make superior focused sequencing dramatically sooner, less complicated and extra accessible.
6. What makes AVITI24 transformative?
AVITI24, our 5D multi-omics system, is the primary platform that permits scientists to combine spatial and single-cell multi-omics. It captures DNA, RNA, protein, and morphology in a single run. When mixed with our high-quality sequencing, researchers achieve a whole view of mobile biology –each spatially and genomically.
We actually imagine that is the way forward for how scientific discovery shall be accomplished, and it’s obtainable at this time. AVITI24 empowers researchers to drive therapeutic breakthroughs in methods no different know-how can.
7. How have partnerships contributed to Factor’s development, particularly in Asia?
Breakthrough science hardly ever occurs in isolation. It requires shared experience, open platforms, and world networks. Collaboration helps be sure that highly effective applied sciences attain extra scientists and translate into significant affect.
Partnerships with innovators throughout sequencing, evaluation, and diagnostics have helped broaden adoption and speed up new purposes. By working with leaders throughout the ecosystem, we guarantee our know-how helps researchers with the questions they’re looking for to reply, wherever they’re. These collaborations have been instrumental in our world growth as a result of they assist us keep attuned to particular buyer wants.
8. Trying forward, what’s your imaginative and prescient for Factor over the subsequent 5 years?
Over the subsequent 5 years, we’ll proceed increasing our sequencing and multi-omics platforms, bringing even richer organic data to researchers at decrease price. We see Factor turning into a worldwide chief in built-in genomics and multi-omics evaluation.
Whether or not we’re supporting analysis into the subsequent diagnostic breakthrough or accelerating drug growth, our focus is on empowering science in every single place and creating know-how that advances human well being on a worldwide scale.
—
Supply: Factor Biosciences
Disclaimer: This text doesn’t essentially replicate the views of AsianScientist or its workers.
